S&P 500 Futures
(-0.02%) 5 212.50 points
Dow Jones Futures
(-0.02%) 39 021 points
Nasdaq Futures
(-0.01%) 18 198 points
Oil
(-1.40%) $77.28
Gas
(0.23%) $2.21
Gold
(-0.37%) $2 315.70
Silver
(-0.70%) $27.35
Platinum
(-1.07%) $977.80
USD/EUR
(0.13%) $0.931
USD/NOK
(0.42%) $10.95
USD/GBP
(0.27%) $0.802
USD/RUB
(-0.92%) $90.60

リアルタイムの更新: Bliss GVS Pharma Limited [BLISSGVS.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-08)

Expected move: +/- 4.34%

最終更新日時8 5月 2024 @ 18:00

-0.76% INR 111.45

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:00):

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches...

Stats
本日の出来高 171 244
平均出来高 682 219
時価総額 11.67B
EPS INR0 ( 2024-01-22 )
次の収益日 ( INR0 ) 2024-07-30
Last Dividend INR0.500 ( 2023-07-12 )
Next Dividend INR0 ( N/A )
P/E 13.43
ATR14 INR0.0730 (0.07%)

ボリューム 相関

長: -0.03 (neutral)
短: 0.46 (neutral)
Signal:(44.164) Neutral

Bliss GVS Pharma Limited 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bliss GVS Pharma Limited 相関 - 通貨/商品

The country flag 0.36
( neutral )
The country flag 0.05
( neutral )
The country flag 0.00
( neutral )
The country flag 0.70
( moderate )
The country flag -0.02
( neutral )
The country flag 0.53
( weak )

Bliss GVS Pharma Limited 財務諸表

Annual 2022
収益: INR7.52B
総利益: INR3.50B (46.60 %)
EPS: INR6.83
FY 2022
収益: INR7.52B
総利益: INR3.50B (46.60 %)
EPS: INR6.83
FY 2022
収益: INR7.38B
総利益: INR3.47B (47.02 %)
EPS: INR2.24
FY 2021
収益: INR5.69B
総利益: INR2.40B (42.16 %)
EPS: INR6.64

Financial Reports:

No articles found.

Bliss GVS Pharma Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0.500
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Bliss GVS Pharma Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.34 - low (44.24%) | Divividend Growth Potential Score: 4.25 - Stable (14.91%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR0.300 2010-11-25
Last Dividend INR0.500 2023-07-12
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 19 --
Total Paid Out INR9.35 --
Avg. Dividend % Per Year 0.46% --
Score 2.17 --
Div. Sustainability Score 4.34
Div.Growth Potential Score 4.25
Div. Directional Score 4.30 --
Next Divdend (Est)
(2024-12-10)
INR0.496 Estimate 3.25 %
Dividend Stability
0.26 Very Poor
Dividend Score
2.17
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR1.000 0.48%
2019 INR1.000 0.61%
2020 INR0.500 0.34%
2021 INR1.000 0.49%
2022 INR1.000 0.96%
2023 INR0.500 0.69%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
STARPAPER.NS Dividend Junior 2023-09-15 Sporadic 22 1.19%
MUNJALAU.NS Dividend Junior 2023-08-24 Sporadic 19 1.47%
HINDCOMPOS.NS Dividend Junior 2023-09-22 Annually 23 0.50%
BODALCHEM.NS Dividend Junior 2023-09-22 Annually 14 0.38%
RELAXO.NS Dividend Junior 2023-08-17 Annually 14 0.17%
KRBL.NS Dividend Junior 2023-08-25 Annually 23 0.61%
FCL.NS Dividend Junior 2023-09-08 Annually 10 0.22%
ANANTRAJ.NS Dividend Junior 2023-06-27 Annually 18 0.22%
TATACOFFEE.NS Dividend Junior 2023-05-15 Annually 23 0.85%
NIACL.NS No Dividend Player 2023-09-07 Sporadic 7 0.44%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1161.5007.6810.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1291.5009.6810.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM12.331.0006.546.54[3 - 30]
operatingCashFlowPerShareTTM2.702.009.1010.00[0 - 30]
freeCashFlowPerShareTTM2.702.008.6510.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.4771.0005.385.38[0.2 - 0.8]
operatingProfitMarginTTM0.1651.0008.698.69[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.34

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.401.0008.750[1 - 100]
returnOnEquityTTM0.1292.509.7910.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.702.009.1010.00[0 - 30]
dividendYielPercentageTTM0.4441.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM2.702.009.1010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.03641.500-3.090[0.5 - 2]
operatingCashFlowSalesRatioTTM0.03731.000-1.5660[0.1 - 0.5]
Total Score4.25

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。